Scott M Rocklage - Net Worth and Insider Trading
Scott M Rocklage Net Worth
The estimated net worth of Scott M Rocklage is at least $2 Million dollars as of 2024-04-24. Scott M Rocklage is the Director, 10% Owner of Relypsa Inc and owns about 62,316 shares of Relypsa Inc (RLYP) stock worth over $2 Million. Scott M Rocklage is the Director, 10% Owner of Aprea Therapeutics Inc and owns about 75,965 shares of Aprea Therapeutics Inc (APRE) stock worth over $407,932. Scott M Rocklage is also the Director of Pulmatrix Inc and owns about 844 shares of Pulmatrix Inc (PULM) stock worth over $1,705. Details can be seen in Scott M Rocklage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott M Rocklage has not made any transactions after 2020-06-16 and currently still holds the listed stock(s).
Transaction Summary of Scott M Rocklage
Scott M Rocklage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott M Rocklage owns 21 companies in total, including Aprea Therapeutics Inc () , Akouos Inc () , and Cabaletta Bio Inc () among others .
Click here to see the complete history of Scott M Rocklage’s form 4 insider trades.
Insider Ownership Summary of Scott M Rocklage
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Aprea Therapeutics Inc | 2020-06-30 | director | |
Akouos Inc | 2020-06-25 | 10 percent owner | |
Cabaletta Bio Inc | 2019-10-24 | 10 percent owner | |
Arvinas Inc | 2018-09-26 | 10 percent owner | |
Crinetics Pharmaceuticals Inc | 2018-07-17 | 10 percent owner | |
IDEAYA Biosciences Inc | 2020-11-11 | 10 percent owner & Former 10% holder | |
Homology Medicines Inc | 2018-03-27 | 10 percent owner | |
Cidara Therapeutics Inc | 2015-04-14 | director & 10 percent owner | |
scPharmaceuticals Inc | 2017-11-16 | 10 percent owner | |
Audentes Therapeutics Inc | 2017-04-24 | other: former 10% owner | |
PhaseRx Inc | 2016-05-17 | 10 percent owner | |
Pulmatrix Inc | 2016-02-03 | director | |
EPIRUS Biopharmaceuticals Inc | 2015-06-05 | director & 10 percent owner | |
Viveve Medical Inc | 2014-09-23 | 10 percent owner | |
Achaogen Inc | 2014-03-11 | director | |
Relypsa Inc | 2013-11-20 | director & 10 percent owner | |
IPI Legacy Liquidation Co | 2021-04-22 | 10 percent owner | |
Entrada Therapeutics Inc | 2021-10-28 | 10 percent owner | |
Rallybio Corp | 2021-07-29 | 10 percent owner | |
Pear Therapeutics Inc | 2021-12-03 | 10 percent owner | |
Skye Bioscience Inc | 2023-08-18 | 10 percent owner |
Scott M Rocklage Latest Holdings Summary
Scott M Rocklage currently owns a total of 3 stocks. Among these stocks, Scott M Rocklage owns 62,316 shares of Relypsa Inc (RLYP) as of November 20, 2013, with a value of $2 Million and a weighting of 82.95%. Scott M Rocklage owns 75,965 shares of Aprea Therapeutics Inc (APRE) as of June 16, 2020, with a value of $407,932 and a weighting of 16.98%. Scott M Rocklage also owns 844 shares of Pulmatrix Inc (PULM) as of June 16, 2015, with a value of $1,705 and a weighting of 0.07%.
Latest Holdings of Scott M Rocklage
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RLYP | Relypsa Inc | 2013-11-20 | 62,316 | 31.99 | 1,993,489 |
APRE | Aprea Therapeutics Inc | 2020-06-16 | 75,965 | 5.37 | 407,932 |
PULM | Pulmatrix Inc | 2015-06-16 | 844 | 2.02 | 1,705 |
Holding Weightings of Scott M Rocklage
Scott M Rocklage Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott M Rocklage has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the acquisition of 9,364 shares on November 20, 2013, which cost Scott M Rocklage around $103,004.
According to the SEC Form 4 filings, Scott M Rocklage has made a total of 3 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Aprea Therapeutics Inc is the sale of 120,164 shares on June 16, 2020, which brought Scott M Rocklage around $4 Million.
According to the SEC Form 4 filings, Scott M Rocklage has made a total of 0 transactions in Pulmatrix Inc (PULM) over the past 5 years. The most-recent trade in Pulmatrix Inc is the acquisition of 194 shares on June 16, 2015, which cost Scott M Rocklage around $266,978.
Insider Trading History of Scott M Rocklage
- 1
Scott M Rocklage Trading Performance
GuruFocus tracks the stock performance after each of Scott M Rocklage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott M Rocklage is 134.21%. GuruFocus also compares Scott M Rocklage's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott M Rocklage within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott M Rocklage's insider trading performs compared to the benchmark.
Performance of Scott M Rocklage
Average Return
34.48%
Outperforming Transactions
67%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 61.05 | 134.21 | 33.88 | 34.48 | 1.8 | -63.27 |
Relative Return to S&P 500(%) | 59.23 | 133.63 | 30.83 | 24.62 | -6.3 | -73.13 |
Scott M Rocklage Ownership Network
Ownership Network List of Scott M Rocklage
Ownership Network Relation of Scott M Rocklage
Scott M Rocklage Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Scott M Rocklage is the director of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Scott M Rocklage made no insider transaction in Aprea Therapeutics Inc (). Other recent insider transactions involving Aprea Therapeutics Inc () include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc () in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc () were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Scott M Rocklage Mailing Address
Above is the net worth, insider trading, and ownership report for Scott M Rocklage. You might contact Scott M Rocklage via mailing address: C/o 5am Ventures, 501 2nd Street, Suite 350, San Francisco Ca 94107.